Andning Med received an investment from KTH Holding to further develop its innovative inhalation guidance device aimed at enhancing the medication adherence of patients with chronic respiratory diseases.

Target Company Overview

Andning Med is a pioneering Swedish company dedicated to enhancing the inhalation techniques of patients suffering from chronic respiratory diseases, particularly Chronic Obstructive Pulmonary Disease (COPD) and asthma. Founded by a dynamic team comprising an engineer, a designer, a doctor, and a business developer, the company was inspired by firsthand experiences of the challenges faced by elderly patients in maintaining correct inhalation practices. The innovative product developed by Andning Med attaches to a patient's inhaler, providing step-by-step guidance, performance feedback, and encouragement to improve inhalation techniques with each use. This functionality is complemented by a mobile application, enabling patients to track their progress and share data with caregivers, thus fostering independent management of their condition without necessitating continuous nursing assistance.

Industry Overview in Sweden

The healthcare landscape in Sweden is renowned for its high standards and emphasis on patient-centered care. With an increasing population of elderly individuals and a rise in respiratory ailments, the demand for effective chronic disease management tools is becoming critical. The Swedish government supports innovation in healthcare through various initiatives aimed at improving health outcomes and accessibility. The country actively encourages the adoption of digital health solutions that empower patients, reflecting a broader global trend towards self-management of health conditions.

Sweden's digital health market is experiencing substantial growth, as more solutions are developed to meet the complex needs of patients. With over 300 million people globally suffering from COPD, and millions more affected by asthma, the potentia